Clinical Trial

Impact of Atrioventricular Delay Optimization on Ventricular Function in Conduction System Pacing

Study acronym: OPTI-CSP
Completed
View on ClinicalTrials.gov →
Summary
Conduction system pacing has emerged as a physiological pacing strategy that preserves ventricular electrical activation and minimizes pacing-induced dyssynchrony. However, the optimal atrioventricular delay setting in patients undergoing conduction system pacing remains uncertain. This study aims to evaluate the effects of individualized echocardiography-guided atrioventricular delay optimization on ventricular function and hemodynamic performance in patients with conduction system pacing. Echocardiographic parameters including global longitudinal strain, left ventricular ejection fraction, left ventricular outflow tract velocity-time integral, cardiac output, and diastolic function indices will be assessed before and after atrioventricular delay optimization. The study will investigate whether optimization of atrioventricular timing provides additional mechanical and hemodynamic benefits beyond physiological ventricular activation achieved by conduction system pacing alone.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-29.
Trial Details
NCT Number NCT07624552
Lead Sponsor Bursa Yuksek Ihtisas Training and Research Hospital
Conditions Atrioventricular Block, Conduction System Pacing
Enrollment 39 participants
Start Date 2025-10-06
Primary Completion 2026-02-17 (estimated)
Study Completion 2026-02-17 (estimated)
Updated on ClinicalTrials.gov 2026-06-08